Annual Working Capital
-$5.96 M
-$8.90 M-302.72%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual working capital is -$5.96 million, with the most recent change of -$8.90 million (-302.72%) on December 31, 2023.
- During the last 3 years, EFTR annual working capital has fallen by -$13.76 million (-176.39%).
- EFTR annual working capital is now -112.18% below its all-time high of $48.92 million, reached on December 31, 2021.
Performance
EFTR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$681.00 K
+$6.64 M+111.43%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly working capital is $681.00 thousand, with the most recent change of +$6.64 million (+111.43%) on March 31, 2024.
- Over the past year, EFTR quarterly working capital has increased by +$6.44 million (+111.83%).
- EFTR quarterly working capital is now -98.61% below its all-time high of $48.92 million, reached on December 31, 2021.
Performance
EFTR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
EFTR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -302.7% | +111.8% |
| 3 y3 years | -176.4% | +111.8% |
| 5 y5 years | -176.4% | +111.8% |
EFTR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -112.2% | at low | -98.6% | +111.4% |
| 5 y | 5-year | -112.2% | at low | -98.6% | +111.4% |
| alltime | all time | -112.2% | at low | -98.6% | +111.4% |
EFFECTOR Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $681.00 K(-111.4%) |
| Dec 2023 | -$5.96 M(-302.7%) | -$5.96 M(+38.4%) |
| Sep 2023 | - | -$4.31 M(-294.3%) |
| Jun 2023 | - | $2.22 M(-138.5%) |
| Mar 2023 | - | -$5.76 M(-295.9%) |
| Dec 2022 | $2.94 M | $2.94 M(-72.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $10.55 M(-43.6%) |
| Jun 2022 | - | $18.70 M(-59.1%) |
| Mar 2022 | - | $45.71 M(-6.6%) |
| Dec 2021 | $48.92 M(+527.2%) | $48.92 M(+288.4%) |
| Sep 2021 | - | $12.59 M(+61.5%) |
| Dec 2020 | $7.80 M | $7.80 M |
FAQ
- What is eFFECTOR Therapeutics annual working capital?
- What is the all time high annual working capital for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual working capital year-on-year change?
- What is eFFECTOR Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly working capital year-on-year change?
What is eFFECTOR Therapeutics annual working capital?
The current annual working capital of EFTR is -$5.96 M
What is the all time high annual working capital for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual working capital is $48.92 M
What is eFFECTOR Therapeutics annual working capital year-on-year change?
Over the past year, EFTR annual working capital has changed by -$8.90 M (-302.72%)
What is eFFECTOR Therapeutics quarterly working capital?
The current quarterly working capital of EFTR is $681.00 K
What is the all time high quarterly working capital for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly working capital is $48.92 M
What is eFFECTOR Therapeutics quarterly working capital year-on-year change?
Over the past year, EFTR quarterly working capital has changed by +$6.44 M (+111.83%)